Recent Finacing
Recent Raise
Elevara Medicines is a London-based clinical-stage biotech developing ELV001, a first-in-class oral CDK4/6 inhibitor for rheumatoid arthritis and other chronic inflammatory diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Elevara Medicines.
